Clinical Integration of Menin Inhibitors in AML: Evolving Data and Therapeutic Perspectives.

bleximenib (JNJ-6617) - J&J, Blackstone Health

icovamenib (BMF-219) - Biomea Fusion

Komzifti (ziftomenib) - Kura Oncology, Kyowa Kirin

Revuforj (revumenib) - Syndax Pharma

http://www.ncbi.nlm.nih.gov/pubmed/41799513

Eduardo Fernandez-Hernandez; Eric L Tam; George Yaghmour; Grace Kim; Karrune Woan; Monisha Kamdar; Tiffany Chen; Yekta Rahimi

Mar 9, 2026